Lv3
250 积分 2021-03-29 加入
Immunoliposome targeting IL-30
2个月前
已完结
Smart Immunoliposome‐Based Targeted Drug Delivery for Cancer: A Comprehensive Systematic Review
2个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
3个月前
已完结
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial
3个月前
已完结
Neoadjuvant therapy in MIBC
3个月前
已完结
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2
4个月前
已完结
Adjuvant bacillus Calmette-Guérin (BCG) immunotherapy versus BCG combined with disitamab vedotin in BCG-naïve high-risk non-muscle invasive bladder cancer with HER2 expression: A real-world study
6个月前
已完结
Bladder-Preserving Trimodality Therapy With Capecitabine
6个月前
已关闭
Efficacy and safety of dose‐dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle‐invasive bladder cancer
6个月前
已完结
Bladder-Preserving Trimodality Therapy With Capecitabine
6个月前
已关闭
皖公网安备34019202002308
